期刊文献+

玻璃体腔注射环孢菌素A对糖尿病大鼠血视网膜屏障的保护作用及机制 被引量:1

The protective effects and mechanism of intravitreal injection with cyclosporin-A on blood-retinal barrier in diabetic rats
原文传递
导出
摘要 目的观察和探讨玻璃体腔注射环孢菌素A(CsA)对糖尿病(DM)大鼠血视网膜屏障(BRB)的影响及其作用机制。方法8~10周龄健康Sprague—Dawley雄性大鼠48只,随机分为正常对照组、DM组、CsA组及二甲基亚砜(DMS0)组,每组12只。对DM、CsA及DMSO组大鼠进行一次性腹腔注射链脲佐菌素(STZ)溶液建模,正常对照组大鼠腹腔注射等量的柠檬酸钠缓冲液。注射后72h,采用免疫组织化学染色法检测视网膜内外渗的内源性白蛋白评价BRB的渗透性;蛋白质免疫印迹法(Western blot)检测视网膜细胞间粘附分子(ICAM-1)的蛋白表达;酶联免疫吸附试验(EusA)检测视网膜血管内皮生长因子(VEGF)的表达。结果与正常对照组相比,DM组大鼠视网膜外渗的白蛋白增多,视网膜内ICAM一1、VEGF表达明显升高,差异均有统计学意义(F=29.350,29.240,9.658;P〈0.01)。与DM组相比,CsA组大鼠视网膜外渗的白蛋白减少,视网膜内ICAM-1、VEGF表达明显下降,差异均有统计学意义(t=3.174,5.000,3.352;P〈0.05);DMSO组大鼠视网膜外渗的白蛋白、视网膜内ICAM-1及VEGF表达均无明显变化,差异无统计学意义(t=0.420,0.561,0.312;P〉0.05)。结论玻璃体腔注射CsA对DM大鼠BRB具有保护作用。其机制可能与CsA降低IcAM-1及VEGF的表达有关。 Objective To investigate the protective effect and mechanism of intravitreal injection with cyclosporiwA(CsA) on blood-retinal barrier (BRB) in diabetic rats. Methods A total of 48 Sprague- Dawley male mice at the age of 8-10 weeks were divided into normal group, diabetes mellitus (DM) group, CsA group and DMSO group, with 12 rats in each group. The rats in DM, CsA group and DMSO group were induced with streptozotocin (STZ) injection creating a diabetic retinopathy model. The same volume of citric sodium citrate buffer was injected into the rats in the normal group. Immunohistochemical staining was used to detect the BRB permeability, Western blot was used to measure the protein expression of intercellular adhesion molecule (ICAM-1). Enzyme-linked immunosorbent assay (ELISA) was used to measure the expression of vascular endothelial growth factor 72 hours after injection. Results Compared with the normal group, the BRB permeability, ICAM-1 and VEGF expression were significantly increased in DM group (F=29. 350, 29. 240, 9. 658; P〈0.01). Compared with the DM group, the BRB permeability, ICAM-1 and VEGF expression were significantly decreased in CsA group (t = 3. 174, 5. 000, 3. 352; P〈0.05) ; but there was no obvious change of above indexes in DMSO group (t=0. 420, 0. 561, 0. 312; P〉 0.05). Conclusion Intravitreal injection of CsA has protective effects on BRB in diabetic rats. Downregulated expression of ICAM-1 and VEGF may be the mechanism.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2012年第3期254-257,共4页 Chinese Journal of Ocular Fundus Diseases
关键词 糖尿病视网膜病变/预防和控制 血视网膜屏障/病理学 环孢菌素/治疗应用 疾病 模型 动物 Diabetic retinopathy/prevention & control Blood-retinal barrier/pathology Cyclosporine/therapeutic use Disease models, animal
  • 相关文献

参考文献19

  • 1Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Springer, 2008, 30..65-84.
  • 2Adams DD. Autoimmune destruction of pericytes as the cause of diabetic retinopathy. Clin Ophthalmol, 2008, 2 ;295-298.
  • 3Zhang X, Bao S, Lai D, et al. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes, 2008, 57 : 1026-1033.
  • 4Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet, 2010, 376:124-136.
  • 5Lallemanda F, Feh-Baeyensa O, Besseghir K, et al. Cyclosporine A delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm, 2003, 56 307 318.
  • 6Carmo A, Cunha-Vaz JG, Carvalho AP, et al. Effect of cyclosporin-A on the blood-retinal barrier permeability in streptozotocin-induced diabetes. Mediators Inflamm, 2000, 9: 243 248.
  • 7Berkowitz BA, Roberts R, Goebel DJ, et al. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci, 2006, 47:2668-2674.
  • 8Tsai TI, Bui BV, Vingrys AJ. Dimethyl sulphoxide dose- response on rat retinal function. Doc Ophthalmol, 2009, 119: 199-207.
  • 9Pearson PA, Jaffe GJ, Martin DF, et al. Evaluation of a delivery system providing long-term release of cyclosporine. Arch Opht halmol, 1996,114 : 311-317.
  • 10Kaji Y, Usui T, Ishida S, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci, 2007,48:858-865.

同被引文献11

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部